Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.99%3.06B | 10.52%2.01B | 11.31%1.07B | -0.56%3.81B | -3.17%2.86B | -5.54%1.82B | -7.10%963.02M | -5.77%3.83B | -5.02%2.96B | -6.13%1.93B |
| Operating income | 6.99%3.06B | 10.52%2.01B | 11.31%1.07B | -0.56%3.81B | -3.17%2.86B | -5.54%1.82B | -7.10%963.02M | -5.77%3.83B | -5.02%2.96B | -6.13%1.93B |
| Cost of sales | -6.14%-1.98B | -12.84%-1.34B | -12.89%-695.88M | 1.20%-2.5B | 4.38%-1.86B | 6.76%-1.19B | 8.18%-616.43M | 8.49%-2.53B | 8.62%-1.95B | 9.82%-1.27B |
| Operating expenses | -6.14%-1.98B | -12.84%-1.34B | -12.89%-695.88M | 1.20%-2.5B | 4.38%-1.86B | 6.76%-1.19B | 8.18%-616.43M | 8.49%-2.53B | 8.62%-1.95B | 9.82%-1.27B |
| Gross profit | 8.57%1.08B | 6.20%676.95M | 8.50%376.05M | 0.69%1.31B | -0.83%997.44M | -3.17%637.45M | -5.11%346.59M | 0.02%1.3B | 2.84%1.01B | 1.95%658.32M |
| Selling expenses | -9.96%-450.79M | -5.84%-276.07M | -10.01%-134.74M | -1.96%-542.07M | 0.80%-409.94M | 5.75%-260.83M | 15.21%-122.48M | 2.00%-531.67M | 2.51%-413.26M | -0.37%-276.75M |
| Administrative expenses | -11.68%-255.64M | -10.87%-164.51M | -14.09%-82.17M | -5.04%-313.07M | 2.73%-228.91M | -0.57%-148.38M | -1.82%-72.02M | 0.73%-298.05M | -8.58%-235.34M | -2.30%-147.54M |
| Impairment and provision | ---- | ---- | ---- | 50.31%-722K | ---- | ---- | ---- | -102.37%-1.45M | ---- | ---- |
| -Other impairment is provision | ---- | ---- | ---- | 50.31%-722K | ---- | ---- | ---- | -102.37%-1.45M | ---- | ---- |
| Special items of operating profit | 50.55%-7.59M | -78.31%-8.05M | -104.88%-203K | -943.70%-152.92M | -244.97%-15.35M | -12.74%-4.51M | 531.67%4.16M | -480.97%-14.65M | 0.35%10.59M | -129.62%-4M |
| Operating profit | 7.49%368.94M | 2.06%228.33M | 1.73%158.94M | -33.66%303.34M | -6.69%343.23M | -2.74%223.73M | 4.79%156.24M | -1.28%457.24M | 5.70%367.83M | -3.87%230.03M |
| Financing cost | 38.85%-192K | 57.40%-95K | 34.78%-75K | -46.67%-396K | -134.33%-314K | -66.42%-223K | -64.29%-115K | -4.25%-270K | 46.40%-134K | 26.37%-134K |
| Earning before tax | 7.53%368.75M | 2.12%228.24M | 1.75%158.86M | -33.71%302.94M | -6.74%342.92M | -2.78%223.51M | 4.76%156.13M | -1.28%456.97M | 5.73%367.69M | -3.85%229.89M |
| Tax | -21.26%-106.01M | -32.81%-68.62M | -27.99%-47.2M | 22.89%-95.48M | 8.38%-87.43M | 9.75%-51.67M | 3.84%-36.88M | -3.19%-123.82M | -6.41%-95.42M | 7.17%-57.24M |
| After-tax profit from continuing operations | 2.83%262.73M | -7.11%159.62M | -6.36%111.67M | -37.73%207.46M | -6.16%255.49M | -0.47%171.84M | 7.74%119.25M | -2.84%333.15M | 5.50%272.27M | -2.70%172.65M |
| Earning after tax | 2.83%262.73M | -7.11%159.62M | -6.36%111.67M | -37.73%207.46M | -6.16%255.49M | -0.47%171.84M | 7.74%119.25M | -2.84%333.15M | 5.50%272.27M | -2.70%172.65M |
| Minority profit | 8.75%4.66M | 10.17%2.59M | 25.67%1.64M | 117.05%6.47M | 124.06%4.28M | 144.64%2.35M | 70.59%1.31M | -90.11%2.98M | -92.41%1.91M | -94.01%961K |
| Profit attributable to shareholders | 2.73%258.07M | -7.35%157.03M | -6.71%110.03M | -39.12%200.99M | -7.08%251.21M | -1.28%169.49M | 7.31%117.95M | 5.57%330.17M | 16.08%270.36M | 6.38%171.69M |
| Basic earnings per share | 2.74%0.2473 | -7.33%0.1505 | -6.73%0.1054 | -39.13%0.1926 | -7.07%0.2407 | -1.28%0.1624 | 7.72%0.113 | 5.61%0.3164 | 16.09%0.259 | 6.40%0.1645 |
| Diluted earnings per share | 2.74%0.2473 | -7.33%0.1505 | -6.73%0.1054 | -39.11%0.1926 | -7.07%0.2407 | -1.28%0.1624 | 7.72%0.113 | 5.57%0.3163 | 16.09%0.259 | 6.40%0.1645 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.